Emergent molecular studies have shown recurrent somatic gain-of-function mutations in genes of the MAPK pathway (e.g., NRAS, KRAS, MAP2K1, and ARAF) in a subset of RDD, suggesting a clonal histiocytic proliferative process. The gene discussed is MAP2K1; the disease is sinus histiocytosis with massive lymphadenopathy.